Migraineurs have long suffered with debilitating headaches, nausea, vomiting, halo effects, interrupted sleep, and missing daily activities, to remain in bed, in the dark, in isolation. Over the years, medicines have been developed that attempt to relieve migraine pain.
In 2018, the FDA approved Rinat Neuroscience’s Ajovy medication for use in adults, via a self-administered injection, which focused on preventing migraines in the first place. Migraine frequency was greatly reduced. In August 2025, Ajovy was approved for children from age 6 upwards. The results have been amazing, with kids now more fully enjoying daily activities with much less frequent migraine episodes.
Show more...